121 related articles for article (PubMed ID: 16044003)
1. CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.
Lin YL; Portales P; Segondy M; Baillat V; de Boever CM; Le Moing V; Réant B; Montes B; Clot J; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2005 Aug; 39(5):530-6. PubMed ID: 16044003
[TBL] [Abstract][Full Text] [Related]
2. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
[TBL] [Abstract][Full Text] [Related]
3. Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.
Schmitt N; Chêne L; Boutolleau D; Nugeyre MT; Guillemard E; Versmisse P; Jacquemot C; Barré-Sinoussi F; Israël N
J Virol; 2003 May; 77(10):5784-93. PubMed ID: 12719571
[TBL] [Abstract][Full Text] [Related]
4. Pairwise comparison of isogenic HIV-1 viruses: R5 phenotype replicates more efficiently than X4 phenotype in primary CD4+ T cells expressing physiological levels of CXCR4.
Fiser AL; Lin YL; Portalès P; Mettling C; Clot J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Feb; 53(2):162-6. PubMed ID: 20051874
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
6. Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.
van Rij RP; Hazenberg MD; van Benthem BH; Otto SA; Prins M; Miedema F; Schuitemaker H
AIDS Res Hum Retroviruses; 2003 May; 19(5):389-98. PubMed ID: 12803997
[TBL] [Abstract][Full Text] [Related]
7. The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.
Gijsbers EF; van Sighem A; Harskamp AM; Welkers MR; de Wolf F; Brinkman K; Prins JM; Schuitemaker H; van 't Wout AB; Kootstra NA
PLoS One; 2013; 8(10):e76255. PubMed ID: 24098454
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains.
Ancuta P; Bakri Y; Chomont N; Hocini H; Gabuzda D; Haeffner-Cavaillon N
J Immunol; 2001 Mar; 166(6):4244-53. PubMed ID: 11238678
[TBL] [Abstract][Full Text] [Related]
10. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
[TBL] [Abstract][Full Text] [Related]
11. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
12. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
[TBL] [Abstract][Full Text] [Related]
13. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
14. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
15. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
[TBL] [Abstract][Full Text] [Related]
16. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP
J Virol; 2006 Jan; 80(2):802-9. PubMed ID: 16378982
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.
Llano A; Barretina J; Gutiérrez A; Blanco J; Cabrera C; Clotet B; Esté JA
J Virol; 2001 Nov; 75(21):10319-25. PubMed ID: 11581400
[TBL] [Abstract][Full Text] [Related]
18. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
[TBL] [Abstract][Full Text] [Related]
20. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.
Delobel P; Sandres-Sauné K; Cazabat M; Pasquier C; Marchou B; Massip P; Izopet J
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):382-92. PubMed ID: 15764954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]